UNBELIEVABLE: Addex rapeutics - The Untold Story

Stocks That Hit 52-Week Lows On Tuesday

  Tuesday saw 37 companies set new 52-week lows.

Benzinga · Jul 19, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022

Upgrades

Benzinga · Jun 23, 2022

Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders

Addex Therapeutics (NASDAQ: ADXN) has moved a selective and potent M4 muscarinic receptor positive allosteric modulator (PAM) program into lead optimization, with a 

Benzinga · Apr 6, 2022